It has fallen pretty hard already from 5.5 to 4 cents on no new news.
$7.5m cash in the bank. So its business is valued at $13.8m.
This is cheap for phase 11A trial, we should start hearing something, given over 40 sites are already active. Hopefully it leads to full remission of MS and, as a side-effect, cures baldness...
